MY118724A - New crystalline form of omeprazole - Google Patents
New crystalline form of omeprazoleInfo
- Publication number
- MY118724A MY118724A MYPI98005336A MYPI9805336A MY118724A MY 118724 A MY118724 A MY 118724A MY PI98005336 A MYPI98005336 A MY PI98005336A MY PI9805336 A MYPI9805336 A MY PI9805336A MY 118724 A MY118724 A MY 118724A
- Authority
- MY
- Malaysia
- Prior art keywords
- methoxy
- crystalline form
- omeprazole
- sulfinyl
- benzimidazole
- Prior art date
Links
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000381 omeprazole Drugs 0.000 title abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical compound S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
THE PRESENT INVENTION RELATES TO A NOVEL CRYSTALLINE FORM OF 5-METHOXY-2[[(4-METHOXY-3,5- OMETHYL-2- PYRIDINY) METHYL] SULFINYL]-1H- BENZIMIDAZOLE, KNOWN UNDER THE GENERIC NAME OMEPRAZOLE. FURTHER, THE PRESENT INVENTION ALSO RELATES TO THE USE OF THE NOVEL CRYSTALLINE FORM OF 5-METHOXY-2-[[(4-METHOXY-3, 5-DIMETHYL-2-PYRIDINY) METHYL]SULFINYL]-H- BENZIMIDAZOLE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AS WELL AS PROCESSES FOR THE PREPARATION OF THE NOVEL CRYSTALLINE FORM OF 5-METHOXY-2-[[(4-METHOXY-3, 5-DIMETHYL-2-PYRIDINYL) METHYL] SULFINYL]-1H- BENZIMIDAZOLE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/SE1998/002028 WO1999008500A2 (en) | 1998-11-10 | 1998-11-10 | New crystalline form of omeprazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY118724A true MY118724A (en) | 2005-01-31 |
Family
ID=43735642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI98005336A MY118724A (en) | 1998-11-10 | 1998-11-24 | New crystalline form of omeprazole |
Country Status (5)
| Country | Link |
|---|---|
| KR (1) | KR100572297B1 (en) |
| AR (1) | AR016700A1 (en) |
| MY (1) | MY118724A (en) |
| SA (1) | SA99190998B1 (en) |
| TN (1) | TNSN98221A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119320381B (en) * | 2024-10-14 | 2025-12-12 | 山东益康药业股份有限公司 | Eutectic of omeprazole and 3, 5-dinitrobenzoic acid and application thereof |
| CN119320380B (en) * | 2024-10-14 | 2025-11-25 | 山东益康药业股份有限公司 | Omeprazole and 2,6-dihydroxybenzoic acid cocrystals and their uses |
-
1998
- 1998-11-10 KR KR1020017005830A patent/KR100572297B1/en not_active Expired - Fee Related
- 1998-11-24 MY MYPI98005336A patent/MY118724A/en unknown
- 1998-11-25 AR ARP980105984A patent/AR016700A1/en active IP Right Grant
- 1998-12-08 TN TNTNSN98221A patent/TNSN98221A1/en unknown
-
1999
- 1999-01-26 SA SA99190998A patent/SA99190998B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SA99190998B1 (en) | 2006-03-25 |
| TNSN98221A1 (en) | 2005-03-15 |
| KR20010107953A (en) | 2001-12-07 |
| AR016700A1 (en) | 2001-07-25 |
| KR100572297B1 (en) | 2006-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1999008500A3 (en) | New crystalline form of omeprazole | |
| MY127871A (en) | Omeprazole sodium salt | |
| MY119095A (en) | Potassium salt of (s)-omeprazole | |
| WO1998054171A8 (en) | Novel form of s-omeprazole | |
| UA32524C2 (en) | A process for preparation of omeprazole | |
| ZA200307988B (en) | Crystalline form of omerprazole. | |
| MY118724A (en) | New crystalline form of omeprazole | |
| MXPA05009183A (en) | Polymorphs of s-omeprazole. | |
| YU32301A (en) | New crystalline form of omeprazole |